Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice

Synthesis and Structure–Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists

(2014) Martin Hansen et al.   ACS Chemical Neuroscience

Pathological Findings in 2 Cases of Fatal 25I-NBOMe Toxicity

(2014) Jeffrey P. Walterscheid et al.   AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY

Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe

(2014) M. H. Y. Tang et al.   CLINICAL TOXICOLOGY

The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample

(2014) Will Lawn et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response

(2013) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

Extensive Rigid Analogue Design Maps the Binding Conformation of Potent N-Benzylphenethylamine 5-HT2A Serotonin Receptor Agonist Ligands

(2012) Jose I. Juncosa et al.   ACS Chemical Neuroscience

Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model

(2012) Clint E. Canal et al.   Drug Testing and Analysis

Interaction of 5-HT2A and 5-HT2C Receptors in R(-)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice

(2010) W. E. Fantegrossi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane (DOM), Ketanserin, and (R)-(+)- -(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in Rats

(2009) J.-X. Li et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): A high-affinity 5-HT2A receptor-selective agonist radioligand

(2008) David E. Nichols et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Structure-Activity Relationships of Phenylalkylamines as Agonist Ligands for 5-HT2AReceptors

(2008) Antoni R. Blaazer et al.   ChemMedChem

The behavioral pharmacology of hallucinogens

(2007) William E. Fantegrossi et al.   BIOCHEMICAL PHARMACOLOGY